| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| 6.5 | - | 1 | 2.5 | 213 | 1,913.3 | 124.9 | 13 | - | - | 2,274.1 |
| 0.5 | - | - | 0.5 | 45.9 | 438 | 24.4 | 4 | - | - | 513.3 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 10 |
| 2 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 15,843 | 99.7% | -2.15 | 3,580 | 99.7% |
| Optic-unspecified(L) | 37 | 0.2% | -2.21 | 8 | 0.2% |
| AME(L) | 10 | 0.1% | -2.32 | 2 | 0.1% |
| upstream partner | # | NT | conns Cm26 | % In | CV |
|---|---|---|---|---|---|
| Tm5b (L) | 227 | ACh | 595.1 | 27.1% | 0.5 |
| TmY5a (L) | 436 | Glu | 178.4 | 8.1% | 0.7 |
| Tm29 (L) | 208 | Glu | 122.7 | 5.6% | 0.8 |
| Tm38 (L) | 84 | ACh | 110.1 | 5.0% | 0.9 |
| Tm5c (L) | 222 | Glu | 107.4 | 4.9% | 0.7 |
| Dm8a (L) | 204 | Glu | 100.3 | 4.6% | 0.7 |
| Cm17 (L) | 15 | GABA | 91.7 | 4.2% | 0.6 |
| Cm11a (L) | 33 | ACh | 91.1 | 4.2% | 0.5 |
| Mi10 (L) | 140 | ACh | 80.3 | 3.7% | 0.7 |
| Tm30 (L) | 61 | GABA | 80.1 | 3.6% | 0.5 |
| Cm10 (L) | 43 | GABA | 80 | 3.6% | 0.7 |
| Tm5Y (L) | 176 | ACh | 76.4 | 3.5% | 0.7 |
| Cm29 (L) | 3 | GABA | 52.6 | 2.4% | 0.2 |
| Cm19 (L) | 16 | GABA | 44.7 | 2.0% | 0.6 |
| Cm28 (L) | 6 | Glu | 39.1 | 1.8% | 0.8 |
| Tm26 (L) | 51 | ACh | 36.9 | 1.7% | 0.8 |
| Cm31a (L) | 2 | GABA | 30.4 | 1.4% | 0.1 |
| MeVC9 (R) | 1 | ACh | 30 | 1.4% | 0.0 |
| Tm5a (L) | 89 | ACh | 19.4 | 0.9% | 0.5 |
| aMe17b (L) | 3 | GABA | 16 | 0.7% | 0.4 |
| LT58 (L) | 1 | Glu | 13.3 | 0.6% | 0.0 |
| TmY17 (L) | 52 | ACh | 11.4 | 0.5% | 0.5 |
| MeVP7 (L) | 10 | ACh | 10.6 | 0.5% | 0.7 |
| MeVP43 (L) | 1 | ACh | 9.4 | 0.4% | 0.0 |
| Tm40 (L) | 14 | ACh | 9.3 | 0.4% | 1.2 |
| Dm2 (L) | 22 | ACh | 9 | 0.4% | 1.1 |
| Cm32 (L) | 1 | GABA | 7.9 | 0.4% | 0.0 |
| Cm31b (L) | 1 | GABA | 7.3 | 0.3% | 0.0 |
| Cm5 (L) | 24 | GABA | 6.6 | 0.3% | 0.6 |
| Tm39 (L) | 33 | ACh | 6.1 | 0.3% | 0.4 |
| Cm7 (L) | 21 | Glu | 5.9 | 0.3% | 1.4 |
| TmY21 (L) | 27 | ACh | 5.7 | 0.3% | 0.5 |
| MeVP2 (L) | 21 | ACh | 5.1 | 0.2% | 0.5 |
| MeLo4 (L) | 15 | ACh | 4.6 | 0.2% | 0.5 |
| Cm1 (L) | 22 | ACh | 4.4 | 0.2% | 0.6 |
| Tm37 (L) | 18 | Glu | 4.3 | 0.2% | 1.0 |
| Cm15 (L) | 16 | GABA | 4.1 | 0.2% | 0.7 |
| MeLo3b (L) | 11 | ACh | 4 | 0.2% | 0.5 |
| Cm2 (L) | 18 | ACh | 3.6 | 0.2% | 0.8 |
| Dm9 (L) | 13 | Glu | 3.3 | 0.1% | 0.6 |
| Mi15 (L) | 12 | ACh | 3.1 | 0.1% | 0.7 |
| MeVP52 (L) | 1 | ACh | 3 | 0.1% | 0.0 |
| MeVPMe13 (R) | 1 | ACh | 2.7 | 0.1% | 0.0 |
| Dm8b (L) | 17 | Glu | 2.7 | 0.1% | 0.3 |
| Tm33 (L) | 15 | ACh | 2.6 | 0.1% | 0.5 |
| MeVP63 (L) | 1 | GABA | 2.4 | 0.1% | 0.0 |
| OA-AL2i4 (L) | 1 | OA | 2.4 | 0.1% | 0.0 |
| Cm35 (L) | 1 | GABA | 2.4 | 0.1% | 0.0 |
| TmY9b (L) | 10 | ACh | 2.4 | 0.1% | 0.5 |
| Cm21 (L) | 5 | GABA | 2.4 | 0.1% | 0.7 |
| Cm3 (L) | 11 | GABA | 2 | 0.1% | 0.3 |
| TmY10 (L) | 11 | ACh | 1.9 | 0.1% | 0.3 |
| MeVC6 (R) | 1 | ACh | 1.7 | 0.1% | 0.0 |
| aMe17e (L) | 1 | Glu | 1.7 | 0.1% | 0.0 |
| aMe4 (L) | 3 | ACh | 1.7 | 0.1% | 0.5 |
| Cm34 (L) | 1 | Glu | 1.6 | 0.1% | 0.0 |
| MeVC22 (L) | 2 | Glu | 1.6 | 0.1% | 0.6 |
| Cm20 (L) | 5 | GABA | 1.6 | 0.1% | 0.5 |
| MeLo3a (L) | 7 | ACh | 1.6 | 0.1% | 0.5 |
| MeVP33 (L) | 1 | ACh | 1.3 | 0.1% | 0.0 |
| Pm4 (L) | 4 | GABA | 1.3 | 0.1% | 0.7 |
| Cm9 (L) | 6 | Glu | 1.3 | 0.1% | 0.3 |
| Cm24 (L) | 2 | Glu | 1.1 | 0.1% | 0.8 |
| OA-ASM1 (R) | 2 | OA | 1.1 | 0.1% | 0.8 |
| MeVP8 (L) | 3 | ACh | 1.1 | 0.1% | 0.5 |
| MeTu3c (L) | 7 | ACh | 1.1 | 0.1% | 0.3 |
| aMe12 (L) | 4 | ACh | 1.1 | 0.1% | 0.4 |
| MeVP32 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP3 (L) | 3 | ACh | 1 | 0.0% | 0.8 |
| MeTu3b (L) | 6 | ACh | 1 | 0.0% | 0.3 |
| aMe5 (L) | 3 | ACh | 0.9 | 0.0% | 0.7 |
| aMe17a (L) | 1 | unc | 0.7 | 0.0% | 0.0 |
| MeVC1 (R) | 1 | ACh | 0.7 | 0.0% | 0.0 |
| MeVPMe13 (L) | 1 | ACh | 0.7 | 0.0% | 0.0 |
| TmY4 (L) | 3 | ACh | 0.7 | 0.0% | 0.3 |
| MeVP21 (L) | 2 | ACh | 0.7 | 0.0% | 0.2 |
| Tm31 (L) | 4 | GABA | 0.7 | 0.0% | 0.3 |
| MeVC8 (R) | 1 | ACh | 0.6 | 0.0% | 0.0 |
| C2 (L) | 1 | GABA | 0.6 | 0.0% | 0.0 |
| aMe30 (L) | 2 | Glu | 0.6 | 0.0% | 0.5 |
| aMe1 (L) | 2 | GABA | 0.6 | 0.0% | 0.5 |
| Tm20 (L) | 2 | ACh | 0.6 | 0.0% | 0.5 |
| Cm11c (L) | 2 | ACh | 0.6 | 0.0% | 0.5 |
| aMe2 (L) | 2 | Glu | 0.6 | 0.0% | 0.5 |
| MeVP6 (L) | 2 | Glu | 0.6 | 0.0% | 0.5 |
| Mi18 (L) | 3 | GABA | 0.6 | 0.0% | 0.4 |
| Mi16 (L) | 3 | GABA | 0.6 | 0.0% | 0.4 |
| R7_unclear | 1 | HA | 0.4 | 0.0% | 0.0 |
| MeVP29 (L) | 1 | ACh | 0.4 | 0.0% | 0.0 |
| MeVP41 (L) | 1 | ACh | 0.4 | 0.0% | 0.0 |
| Cm27 (L) | 1 | Glu | 0.4 | 0.0% | 0.0 |
| MeVP40 (L) | 1 | ACh | 0.4 | 0.0% | 0.0 |
| ME_unclear (L) | 2 | Glu | 0.4 | 0.0% | 0.3 |
| Cm11b (L) | 2 | ACh | 0.4 | 0.0% | 0.3 |
| Tm12 (L) | 2 | ACh | 0.4 | 0.0% | 0.3 |
| OA-ASM1 (L) | 2 | OA | 0.4 | 0.0% | 0.3 |
| Cm26 (L) | 3 | Glu | 0.4 | 0.0% | 0.0 |
| MeTu4f (L) | 3 | ACh | 0.4 | 0.0% | 0.0 |
| MeTu1 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| Cm14 (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| Lawf1 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| MeVC23 (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| MeVC11 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| MeVPMe5 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| aMe26 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| 5-HTPMPV03 (L) | 1 | 5-HT | 0.3 | 0.0% | 0.0 |
| Cm8 (L) | 2 | GABA | 0.3 | 0.0% | 0.0 |
| MeVP10 (L) | 2 | ACh | 0.3 | 0.0% | 0.0 |
| Dm4 (L) | 2 | Glu | 0.3 | 0.0% | 0.0 |
| Cm23 (L) | 2 | Glu | 0.3 | 0.0% | 0.0 |
| Dm11 (L) | 2 | Glu | 0.3 | 0.0% | 0.0 |
| OLVC2 (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| TmY18 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| TmY9a (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVP1 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| TmY13 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm11d (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVP9 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPMe7 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Tm32 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Cm13 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeTu4d (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm6 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| MeVP42 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPMe3 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVPMe11 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVPLo2 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| L5 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| DNc01 (R) | 1 | unc | 0.1 | 0.0% | 0.0 |
| MeLo6 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Tm36 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPMe9 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVC27 (R) | 1 | unc | 0.1 | 0.0% | 0.0 |
| MeVPOL1 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeTu4c (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVC2 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPMe7 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| OA-AL2i3 (L) | 1 | OA | 0.1 | 0.0% | 0.0 |
| downstream partner | # | NT | conns Cm26 | % Out | CV |
|---|---|---|---|---|---|
| Tm5b (L) | 211 | ACh | 235.6 | 14.7% | 0.6 |
| Tm5Y (L) | 261 | ACh | 190.6 | 11.9% | 0.7 |
| Tm29 (L) | 208 | Glu | 186.7 | 11.7% | 0.6 |
| Tm5a (L) | 218 | ACh | 138.3 | 8.6% | 0.7 |
| Tm39 (L) | 153 | ACh | 79.9 | 5.0% | 0.7 |
| Cm17 (L) | 15 | GABA | 78.7 | 4.9% | 0.4 |
| Cm6 (L) | 80 | GABA | 72 | 4.5% | 0.8 |
| TmY5a (L) | 255 | Glu | 69.3 | 4.3% | 0.6 |
| Cm29 (L) | 3 | GABA | 56.4 | 3.5% | 0.5 |
| TmY21 (L) | 101 | ACh | 46.7 | 2.9% | 0.7 |
| Cm19 (L) | 16 | GABA | 38.6 | 2.4% | 0.6 |
| Tm5c (L) | 125 | Glu | 32.9 | 2.1% | 0.6 |
| Tm36 (L) | 57 | ACh | 30.4 | 1.9% | 0.8 |
| Tm31 (L) | 45 | GABA | 24.3 | 1.5% | 0.7 |
| MeVP41 (L) | 1 | ACh | 19.7 | 1.2% | 0.0 |
| Tm30 (L) | 43 | GABA | 17 | 1.1% | 0.8 |
| Tm38 (L) | 49 | ACh | 15 | 0.9% | 0.7 |
| MeVP21 (L) | 3 | ACh | 14.4 | 0.9% | 0.2 |
| MeTu3b (L) | 24 | ACh | 13 | 0.8% | 1.0 |
| MeVP2 (L) | 25 | ACh | 11.7 | 0.7% | 0.7 |
| Pm4 (L) | 13 | GABA | 10.9 | 0.7% | 0.6 |
| T2a (L) | 47 | ACh | 10.3 | 0.6% | 0.4 |
| Dm2 (L) | 24 | ACh | 9.9 | 0.6% | 1.0 |
| aMe5 (L) | 16 | ACh | 9.6 | 0.6% | 0.8 |
| Cm7 (L) | 33 | Glu | 9.6 | 0.6% | 0.6 |
| Tm40 (L) | 21 | ACh | 9.4 | 0.6% | 1.1 |
| Tm33 (L) | 43 | ACh | 9.1 | 0.6% | 0.4 |
| Cm11b (L) | 17 | ACh | 7.7 | 0.5% | 0.6 |
| MeLo4 (L) | 21 | ACh | 7.3 | 0.5% | 0.7 |
| Dm8b (L) | 26 | Glu | 6.3 | 0.4% | 0.6 |
| MeTu3c (L) | 23 | ACh | 5.9 | 0.4% | 0.6 |
| MeTu4a (L) | 15 | ACh | 5.6 | 0.3% | 0.7 |
| Tm37 (L) | 27 | Glu | 5.4 | 0.3% | 0.5 |
| Cm31a (L) | 2 | GABA | 5 | 0.3% | 0.0 |
| Dm8a (L) | 27 | Glu | 5 | 0.3% | 0.5 |
| MeTu1 (L) | 17 | ACh | 4.9 | 0.3% | 0.5 |
| Tm26 (L) | 20 | ACh | 4.9 | 0.3% | 0.7 |
| Tm12 (L) | 23 | ACh | 4.6 | 0.3% | 0.4 |
| MeVP36 (L) | 1 | ACh | 4.3 | 0.3% | 0.0 |
| MeVP27 (L) | 1 | ACh | 4 | 0.2% | 0.0 |
| MeVPMe13 (L) | 1 | ACh | 3.9 | 0.2% | 0.0 |
| Cm28 (L) | 6 | Glu | 3.9 | 0.2% | 1.3 |
| Cm9 (L) | 19 | Glu | 3.9 | 0.2% | 0.5 |
| T2 (L) | 18 | ACh | 3.7 | 0.2% | 0.3 |
| Cm34 (L) | 1 | Glu | 3.6 | 0.2% | 0.0 |
| MeVP8 (L) | 5 | ACh | 3.3 | 0.2% | 0.7 |
| Cm1 (L) | 13 | ACh | 3 | 0.2% | 0.5 |
| Cm31b (L) | 1 | GABA | 2.9 | 0.2% | 0.0 |
| TmY10 (L) | 15 | ACh | 2.9 | 0.2% | 0.6 |
| MeVP43 (L) | 1 | ACh | 2.7 | 0.2% | 0.0 |
| MeVP47 (L) | 1 | ACh | 2.7 | 0.2% | 0.0 |
| Cm11a (L) | 9 | ACh | 2.6 | 0.2% | 0.4 |
| Cm2 (L) | 10 | ACh | 2.3 | 0.1% | 0.8 |
| LT58 (L) | 1 | Glu | 2.1 | 0.1% | 0.0 |
| MeVP7 (L) | 7 | ACh | 2.1 | 0.1% | 0.8 |
| Mi18 (L) | 9 | GABA | 2.1 | 0.1% | 0.7 |
| Tm35 (L) | 9 | Glu | 2.1 | 0.1% | 0.5 |
| Tm20 (L) | 10 | ACh | 2 | 0.1% | 0.5 |
| Cm3 (L) | 11 | GABA | 2 | 0.1% | 0.3 |
| Tm34 (L) | 9 | Glu | 2 | 0.1% | 0.3 |
| TmY18 (L) | 10 | ACh | 1.9 | 0.1% | 0.5 |
| MeVP33 (L) | 1 | ACh | 1.7 | 0.1% | 0.0 |
| MeVP52 (L) | 1 | ACh | 1.7 | 0.1% | 0.0 |
| MeVP6 (L) | 5 | Glu | 1.6 | 0.1% | 0.7 |
| Cm32 (L) | 1 | GABA | 1.4 | 0.1% | 0.0 |
| MeTu3a (L) | 3 | ACh | 1.3 | 0.1% | 0.7 |
| MeVP63 (L) | 1 | GABA | 1.3 | 0.1% | 0.0 |
| Mi10 (L) | 8 | ACh | 1.1 | 0.1% | 0.0 |
| Cm15 (L) | 5 | GABA | 1 | 0.1% | 0.6 |
| aMe12 (L) | 3 | ACh | 1 | 0.1% | 0.5 |
| Cm11d (L) | 4 | ACh | 0.9 | 0.1% | 0.3 |
| MeLo3a (L) | 5 | ACh | 0.9 | 0.1% | 0.3 |
| MeVPMe7 (L) | 1 | Glu | 0.9 | 0.1% | 0.0 |
| Lawf1 (L) | 1 | ACh | 0.7 | 0.0% | 0.0 |
| Mi4 (L) | 2 | GABA | 0.7 | 0.0% | 0.2 |
| TmY17 (L) | 4 | ACh | 0.7 | 0.0% | 0.3 |
| Tm16 (L) | 1 | ACh | 0.6 | 0.0% | 0.0 |
| Cm23 (L) | 2 | Glu | 0.6 | 0.0% | 0.5 |
| MeVC11 (R) | 1 | ACh | 0.6 | 0.0% | 0.0 |
| Cm5 (L) | 3 | GABA | 0.6 | 0.0% | 0.4 |
| MeVPLp1 (L) | 1 | ACh | 0.6 | 0.0% | 0.0 |
| MeVP12 (L) | 2 | ACh | 0.6 | 0.0% | 0.0 |
| Mi9 (L) | 4 | Glu | 0.6 | 0.0% | 0.0 |
| Dm9 (L) | 4 | Glu | 0.6 | 0.0% | 0.0 |
| Y14 (L) | 1 | Glu | 0.4 | 0.0% | 0.0 |
| TmY4 (L) | 2 | ACh | 0.4 | 0.0% | 0.3 |
| Tm2 (L) | 2 | ACh | 0.4 | 0.0% | 0.3 |
| aMe10 (L) | 1 | ACh | 0.4 | 0.0% | 0.0 |
| ME_unclear (L) | 2 | Glu | 0.4 | 0.0% | 0.3 |
| TmY14 (L) | 2 | unc | 0.4 | 0.0% | 0.3 |
| TmY3 (L) | 3 | ACh | 0.4 | 0.0% | 0.0 |
| Cm26 (L) | 3 | Glu | 0.4 | 0.0% | 0.0 |
| Mi13 (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| Cm21 (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| MeVP9 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| MeVPMe7 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| Cm35 (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| Cm-DRA (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| MeVP49 (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| Mi2 (L) | 2 | Glu | 0.3 | 0.0% | 0.0 |
| Tm6 (L) | 2 | ACh | 0.3 | 0.0% | 0.0 |
| aMe3 (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| MeVPMe4 (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| Tm4 (L) | 2 | ACh | 0.3 | 0.0% | 0.0 |
| Tm9 (L) | 2 | ACh | 0.3 | 0.0% | 0.0 |
| aMe1 (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| MeVP42 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| MeLo6 (L) | 2 | ACh | 0.3 | 0.0% | 0.0 |
| TmY9b (L) | 2 | ACh | 0.3 | 0.0% | 0.0 |
| TmY20 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| OA-AL2i4 (L) | 1 | OA | 0.1 | 0.0% | 0.0 |
| Cm4 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVPMe13 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| TmY13 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeLo3b (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| SLP250 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Mi1 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| DNc01 (R) | 1 | unc | 0.1 | 0.0% | 0.0 |
| MeVP3 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Dm11 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Tm32 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVP1 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVC21 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Cm10 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Cm16 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Tm3 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| aMe26 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeTu2b (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm13 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| PVLP046 (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| MeVPMe2 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| aMe6a (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeTu4f (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVP10 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm8 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| MeVC9 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |